Literature DB >> 23738515

Characterization of uterine leiomyomas by whole-genome sequencing.

Miika Mehine1, Eevi Kaasinen, Netta Mäkinen, Riku Katainen, Kati Kämpjärvi, Esa Pitkänen, Hanna-Riikka Heinonen, Ralf Bützow, Outi Kilpivaara, Anna Kuosmanen, Heikki Ristolainen, Massimiliano Gentile, Jari Sjöberg, Pia Vahteristo, Lauri A Aaltonen.   

Abstract

BACKGROUND: Uterine leiomyomas are benign but affect the health of millions of women. A better understanding of the molecular mechanisms involved may provide clues to the prevention and treatment of these lesions.
METHODS: We performed whole-genome sequencing and gene-expression profiling of 38 uterine leiomyomas and the corresponding myometrium from 30 women.
RESULTS: Identical variants observed in some separate tumor nodules suggested that these nodules have a common origin. Complex chromosomal rearrangements resembling chromothripsis were a common feature of leiomyomas. These rearrangements are best explained by a single event of multiple chromosomal breaks and random reassembly. The rearrangements created tissue-specific changes consistent with a role in the initiation of leiomyoma, such as translocations of the HMGA2 and RAD51B loci and aberrations at the COL4A5-COL4A6 locus, and occurred in the presence of normal TP53 alleles. In some cases, separate events had occurred more than once in single tumor-cell lineages.
CONCLUSIONS: Chromosome shattering and reassembly resembling chromothripsis (a single genomic event that results in focal losses and rearrangements in multiple genomic regions) is a major cause of chromosomal abnormalities in uterine leiomyomas; we propose that tumorigenesis occurs when tissue-specific tumor-promoting changes are formed through these events. Chromothripsis has previously been associated with aggressive cancer; its common occurrence in leiomyomas suggests that it also has a role in the genesis and progression of benign tumors. We observed that multiple separate tumors could be seeded from a single lineage of uterine leiomyoma cells. (Funded by the Academy of Finland Center of Excellence program and others.).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23738515     DOI: 10.1056/NEJMoa1302736

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  97 in total

Review 1.  A review of treatment of uterine leiomyosarcomas.

Authors:  Nicholas Reed
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

2.  A Preliminary Study: Human Fibroid Stro-1+/CD44+ Stem Cells Isolated From Uterine Fibroids Demonstrate Decreased DNA Repair and Genomic Integrity Compared to Adjacent Myometrial Stro-1+/CD44+ Cells.

Authors:  Lauren E Prusinski Fernung; Ayman Al-Hendy; Qiwei Yang
Journal:  Reprod Sci       Date:  2018-06-28       Impact factor: 3.060

3.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

4.  History of uterine leiomyoma and risk of endometrial cancer in black women.

Authors:  Lauren A Wise; Todd R Sponholtz; Lynn Rosenberg; Lucile L Adams-Campbell; Wendy Kuohung; Michael P LaValley; Julie R Palmer
Journal:  Cancer Causes Control       Date:  2016-02-29       Impact factor: 2.506

5.  Moving Toward Individualized Medicine for Uterine Leiomyomas.

Authors:  Shannon K Laughlin-Tommaso; Elizabeth A Stewart
Journal:  Obstet Gynecol       Date:  2018-10       Impact factor: 7.661

6.  A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D.

Authors:  David M Hyman; Michael W Sill; Heather A Lankes; Richard Piekarz; Mark S Shahin; Mildred R Ridgway; Floor Backes; Meaghen E Tenney; Cara A Mathews; James S Hoffman; Carol Aghajanian; Martee L Hensley
Journal:  Gynecol Oncol       Date:  2016-10-27       Impact factor: 5.482

7.  The Genetics of Infertility: Current Status of the Field.

Authors:  Michelle Zorrilla; Alexander N Yatsenko
Journal:  Curr Genet Med Rep       Date:  2013-12-01

8.  Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung.

Authors:  Seung-Hyun Jung; Min Sung Kim; Sung-Hak Lee; Hyun-Chun Park; Hyun Joo Choi; Leeso Maeng; Ki Ouk Min; Jeana Kim; Tae In Park; Ok Ran Shin; Tae-Jung Kim; Haidong Xu; Kyo Young Lee; Tae-Min Kim; Sang Yong Song; Charles Lee; Yeun-Jun Chung; Sug Hyung Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

9.  Shouldn't we care about the biology of benign tumours?

Authors:  Adrian Marino-Enriquez; Christopher D M Fletcher
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

10.  Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.

Authors:  Bernadette Liegl-Atzwanger; Ellen Heitzer; Karin Flicker; Stephanie Müller; Peter Ulz; Ozlen Saglam; Fattaneh Tavassoli; Mojgan Devouassoux-Shisheboran; Jochen Geigl; Farid Moinfar
Journal:  Mod Pathol       Date:  2016-07-01       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.